Race, RNA-based recurrence scores, and survival of early hormone receptor-positive breast cancer: A population-based study

被引：0
|
作者：
Han, Yunan [1 ]
Colditz, Graham A. [1 ]
Liu, Ying [1 ]
机构：
[1] Washington Univ St Louis, St Louis, MO USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-1567
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1567
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
    Lund, Mary Jo
    Trivers, Katrina F.
    Porter, Peggy L.
    Coates, Ralph J.
    Leyland-Jones, Brian
    Brawley, Otis W.
    Flagg, Elaine W.
    O'Regan, Ruth M.
    Gabram, Sheryl G. A.
    Eley, J. William
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (02) : 357 - 370
  • [42] TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer
    Joseph A. Sparano
    Lori J. Goldstein
    Nancy E. Davidson
    George W. Sledge
    Robert Gray
    [J]. Breast Cancer Research and Treatment, 2012, 134 : 751 - 757
  • [43] Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study
    Tan, Yinuo
    Li, Xiaofen
    Chen, Haiyan
    Hu, Yeting
    Jiang, Mengjie
    Fu, Jianfei
    Yuan, Ying
    Ding, Kefeng
    [J]. ONCOTARGET, 2016, 7 (43) : 70991 - 71000
  • [44] TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer
    Sparano, Joseph A.
    Goldstein, Lori J.
    Davidson, Nancy E.
    Sledge, George W., Jr.
    Gray, Robert
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 751 - 757
  • [45] Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study
    Jiang, Xiaofan
    Chen, Guanglei
    Sun, Lisha
    Liu, Chao
    Zhang, Yu
    Liu, Mingxin
    Liu, Caigang
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast Cancer
    Bracken-Clarke, Dara B.
    Lucas, Mairi W.
    Higgins, Michaela J.
    [J]. BREAST CARE, 2017, 12 (03) : 138 - 144
  • [47] Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy
    Montemurro, Filippo
    Aglietta, Massimo
    [J]. ENDOCRINE-RELATED CANCER, 2009, 16 (04) : 1091 - 1102
  • [48] Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer
    Sehdev, S.
    Martin, G.
    Sideris, L.
    Lam, W.
    Brisson, S.
    [J]. CURRENT ONCOLOGY, 2009, 16 : S16 - S25
  • [49] Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer
    Calip, Gregory S.
    Nabulsi, Nadia A.
    Hubbard, Colin
    Asfaw, Alemseged A.
    Lee, Inyoung
    Zhou, Jifang
    Cueto, Jenilee
    Mitra, Debanjali
    Ko, Naomi Y.
    Hoskins, Kent F.
    Law, Ernest H.
    [J]. CANCER CAUSES & CONTROL, 2022, 33 (05) : 793 - 799
  • [50] Updates on Adjuvant Therapy for Early Stage Hormone Receptor-Positive Breast Cancer
    Cavalcante, Ludimila L.
    Santa-Maria, Cesar A.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (12) : 18 - 23
12345